Cellular responses of BRCA1-defective and triple-negative breast cancer cells and in vitro BRCA1 interactions induced by metallo-intercalator ruthenium(II) complexes containing chloro-substituted phenylazopyridine-Reference-Cited by-同舟云学术

Cellular responses of BRCA1-defective and triple-negative breast cancer cells and in vitro BRCA1 interactions induced by metallo-intercalator ruthenium(II) complexes containing chloro-substituted phenylazopyridine

Published:2014-02-07 Issue:1 Volume:14 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Nhukeaw Tidarat,Temboot Pornvichai,Hansongnern Kanidtha,Ratanaphan Adisorn

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/1471-2407-14-73.pdf

Reference61 articles.

1. Cleator S, Heller W, Coombes RC: Triple-negative breast cancer: therapeutic options. Lancet Oncol. 2007, 8: 235-244. 10.1016/S1470-2045(07)70074-8.

2. Perou CM, Sørlie T, Eisen MB, van de Rijn M, Jeffreyk SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge E, Pergamenschikov A, Williams C, Zhu SX, Lùnning PE, Bùrresen-Dale A-L, Brown PO, Botstein D: Molecular portraits of human breast tumours. Nature. 2000, 406: 747-752. 10.1038/35021093.

3. Cleere DW: Triple-negative breast cancer: a clinical update. Commun Oncol. 2010, 7: 203-211. 10.1016/S1548-5315(11)70394-1.

4. Turner N, Moretti E, Siclari O, Migliaccio I, Santarpia L, D’Incalci M, Piccolo S, Veronesi A, Zambelli A, Sal GD, Leo AD: Targeting triple negative breast cancer: Is p53 the answer?. Cancer Treat Rev. 2013, 39: 541-550. 10.1016/j.ctrv.2012.12.001.

5. Hugh J, Hanson J, Cheang MCU, Nielsen TO, Perou CM, Dumontet C, Reed J, Krajewska M, Treilleux I, Rupin M, Magherini E, Mackey J, Martin M, Vogel C: Breast cancer subtypes and response to docetaxel in node-positive breast cancer: use of immunohistochemical definition in the BCIRG 001 trial. J Clin Oncol. 2009, 27: 1168-1176. 10.1200/JCO.2008.18.1024.

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis and anticancer activity of Pd(II) and Pt(II) complexes of dodecyl based dithiocarbamate ligands: Insight into the C-H∙∙∙Pt interaction using X-ray structure, DFT, Hirshfeld surface and AIM analysis;Journal of Molecular Structure;2025-02

2. Iridium(III) coordination compounds based on organophosphorus ancillary ligands showing cytotoxicity against breast cancer cells and Fe(III) luminescent sensing;Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy;2024-09

3. Recent trends in the design and delivery strategies of ruthenium complexes for breast cancer therapy;Dalton Transactions;2024

4. Iridium(III) complexes based on cyanomethane and cyanamide ligands with luminescence quenching properties for Fe(III) sensing and biological activities;Polyhedron;2023-10

5. Recent developments on other platinum metal complexes as target-specific anticancer therapeutics;Coordination Chemistry Reviews;2023-09